Please Wait.....
Report
US and China Pre-Treatment Kit for Molecular Diagnosis of Sepsis Market Research Report Forecast to 2030
Market Report I 2023-10-24 I 70 Pages I Market Research Future
US and China Pre-Treatment Kit for Molecular Diagnosis of Sepsis Market Research Report Forecast to 2030
Market Overview
The growth of the pre-treatment kit for molecular diagnosis of sepsis market is attributed to the Rising incidence of sepsis, advancements in molecular diagnostic technologies, and increasing investment in research and development and increasing geriatric population. However, limited awareness and education is anticipated to hamper market growth.
A pre-treatment kit refers to a collection of components, reagents, and materials used in the initial steps of a diagnostic or analytical process. It is specifically designed to prepare a sample for further analysis or testing. In the context of molecular diagnosis of sepsis, a pre-treatment kit would include items necessary for the collection, preservation, and processing of patient samples to facilitate the accurate and efficient detection of sepsis-causing pathogens or related markers through molecular diagnostic techniques such as PCR or nucleic acid amplification.
The expected growth in the market can be attributed to the growing prevalence of sepsis and increasing geriatric population. However, the market is also held back by a lack of skilled personnel. Nevertheless, it is anticipated that the growing public-private funding for sepsis diagnostic research activities will create lucrative opportunities for the players operating in the US & China pre-treatment kit for molecular diagnosis of sepsis market.
Market Segmentation
Based on product, the US & China pre-treatment kits for molecular diagnosis of sepsis market have been segmented into automated extraction equipment and multi-well chamber construction kits. The multi-well chamber construction kits segment dominated the market in 2022, while the automated extraction equipment segment is projected to be the fastest-growing during the forecast period, 2023-2030.
Regional Analysis
The rising incidence of sepsis, the increasing burden of hospital-acquired infections, a growing number of pneumonia cases, the increase in the number of sepsis procedures, and an increase in funding for sepsis-related research activities are the major factors driving the growth of the US pre-treatment kits for molecular diagnosis of sepsis market.
In China, sepsis is a leading cause of illness and mortality. Sepsis is common in this country due to its vast population and diverse healthcare system. The illness causes a significant strain on healthcare systems, resulting in more hospital admissions, longer hospital stays, and higher healthcare expenses. Additionally, however, in China, various obstacles impede appropriate sepsis care. Limited awareness of sepsis symptoms and early warning signals among healthcare personnel and the public contributes to delayed diagnosis. Furthermore, the lack of standardized methods for sepsis management, as well as variable adherence to existing standards, provide substantial challenges.
Major Players
The key market players are F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc (US), Abbott (US), Siemens Medical Solutions USA, Inc (Germany), and Qiagen (Germany). Other key players contributing to the market growth include T2 Biosystems, Inc (US), Luminex Corporation (US), Bioneer Corporation (South Korea), Cepheid (US), and BioMerieux SA (France).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 11
1.1 OVERVIEW 11
2 MARKET INTRODUCTION 12
2.1 DEFINITION 12
2.2 SCOPE OF THE STUDY 12
2.3 RESEARCH OBJECTIVE 12
2.4 MARKET STRUCTURE 13
2.5 ASSUMPTIONS & LIMITATIONS 13
3 RESEARCH METHODOLOGY 14
3.1 DATA MINING 14
3.2 SECONDARY RESEARCH 15
3.3 PRIMARY RESEARCH 16
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 17
3.5 FORECASTING TECHNIQUES 18
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 19
3.6.1 BOTTOM-UP APPROACH 20
3.6.2 TOP-DOWN APPROACH 20
3.7 DATA TRIANGULATION 21
3.8 VALIDATION 21
4 MARKET DYNAMICS 22
4.1 OVERVIEW 22
4.2 DRIVERS 23
4.2.1 GROWING PREVALENCE OF SEPSIS 23
4.2.2 INCREASING GERIATRIC POPULATION 23
4.3 RESTRAINTS 24
4.3.1 LACK OF SKILLED PERSONNEL 24
4.3.2 LIMITED AWARENESS AND EDUCATION 25
4.4 OPPORTUNITIES 26
4.4.1 GROWING PUBLIC-PRIVATE FUNDING FOR SEPSIS DIAGNOSTIC REASEARCH ACTIVITIES 26
5 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, BY PRODUCT 27
5.1 OVERVIEW 27
5.2 AUTOMATED EXTRACTION EQUIPMENT 29
5.3 MULTI-WELL CHAMBER CONSTRUCTION KITS 29
6 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, BY COUNTRY 30
6.1 OVERVIEW 30
6.1.1 US 32
6.1.2 CHINA 34
7 COMPETITIVE LANDSCAPE 35
7.1 OVERVIEW 35
7.2 COMPETITIVE BENCHMARKING 36
7.3 MAJOR GROWTH STRATEGY IN THE US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET 37
7.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET 37
7.5 KEY DEVELOPMENT ANALYSIS 38
7.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 38
7.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL 38
7.6.2 MERGER/ACQUISITION 38
7.6.3 EXPANSION/ INVESTMENT 39
7.7 MAJOR PLAYERS SALES ANALYSIS 39
7.7.1 SALES 39
7.8 MAJOR PLAYERS R&D ANALYSIS 40
8 COMPANY PROFILES 41
8.1 THERMO FISHER SCIENTIFIC INC. 41
8.1.1 COMPANY OVERVIEW 41
8.1.2 FINANCIAL ANALYSIS 42
8.1.3 PRODUCTS OFFERED 43
8.1.4 KEY DEVELOPMENTS 43
8.1.5 SWOT ANALYSIS 44
8.1.6 KEY STRATEGIES 44
8.2 F. HOFFMANN-LA ROCHE LTD 45
8.2.1 COMPANY OVERVIEW 45
8.2.2 FINANCIAL OVERVIEW 45
8.2.3 PRODUCTS OFFERED 46
8.2.4 KEY DEVELOPMENTS 46
8.2.5 SWOT ANALYSIS 46
8.2.6 KEY STRATEGIES 47
8.3 CEPHEID 48
8.3.1 COMPANY OVERVIEW 48
8.3.2 FINANCIAL OVERVIEW 48
8.3.3 PRODUCT/SERVICE OFFERED 48
8.3.4 KEY DEVELOPMENTS 48
8.3.5 KEY STRATEGIES 48
8.4 BIOMERIEUX SA 49
8.4.1 COMPANY OVERVIEW 49
8.4.2 FINANCIAL OVERVIEW 50
8.4.3 PRODUCTS OFFERED 51
8.4.4 KEY DEVELOPMENTS 51
8.4.5 SWOT ANALYSIS 52
8.4.6 KEY STRATEGIES 52
8.5 SIEMENS MEDICAL SOLUTIONS USA, INC. 53
8.5.1 COMPANY OVERVIEW 53
8.5.2 FINANCIAL OVERVIEW 54
8.5.3 PRODUCTS OFFERED 54
8.5.4 KEY DEVELOPMENTS 54
8.5.5 KEY STRATEGIES 55
8.6 ABBOTT 56
8.6.1 COMPANY OVERVIEW 56
8.6.2 FINANCIAL OVERVIEW 57
8.6.3 PRODUCTS OFFERED 57
8.6.4 KEY DEVELOPMENTS 58
8.6.5 SWOT ANALYSIS 58
8.6.6 KEY STRATEGIES 58
8.7 T2 BIOSYSTEMS, INC 59
8.7.1 COMPANY OVERVIEW 59
8.7.2 FINANCIAL OVERVIEW 60
8.7.3 PRODUCTS OFFERED 60
8.7.4 KEY DEVELOPMENTS 61
8.7.5 KEY STRATEGIES 61
8.8 LUMINEX CORPORATION 62
8.8.1 COMPANY OVERVIEWS 62
8.8.2 FINANCIAL OVERVIEW 62
8.8.3 PRODUCTS OFFERED 62
8.8.4 KEY DEVELOPMENTS 62
8.8.5 KEY STRATEGIES 62
8.9 BIONEER CORPORATION 63
8.9.1 COMPANY OVERVIEW 63
8.9.2 FINANCIAL OVERVIEW 63
8.9.3 PRODUCTS OFFERED 64
8.9.4 KEY DEVELOPMENTS 64
8.9.5 KEY STRATEGIES 64
8.10 QIAGEN 65
8.10.1 COMPANY OVERVIEW 65
8.10.2 FINANCIAL OVERVIEW 66
8.10.3 PRODUCTS OFFERED 66
8.10.4 KEY DEVELOPMENTS 67
8.10.5 SWOT ANALYSIS 67
8.10.6 KEY STRATEGIES 67
9 APPENDIX 68
9.1 REFERENCES 68
9.2 RELATED REPORTS 69
?
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 13
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 16
TABLE 3 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, BY PRODUCT,
2019-2030 (USD MILLION) 28
TABLE 4 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, FOR AUTOMATED
EXTRACTION EQUIPMENT, BY REGION, 2019-2030 (USD MILLION) 29
TABLE 5 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, FOR MULTI-WELL
CHAMBER CONSTRUCTION KITS, BY REGION, 2019-2030 (USD MILLION) 29
TABLE 6 US AND CHINA: PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, BY REGION, 2019-2030 (USD MILLION) 30
TABLE 7 US: PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 33
TABLE 8 CHINA: PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, BY PRODUCT, 2019-2030 (USD MILLION) 34
TABLE 9 MAJOR PLAYERS IN THE US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET 35
TABLE 10 MOST ACTIVE PLAYER IN THE US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET 37
TABLE 11 PRODUCT LAUNCH/PRODUCT APPROVAL 38
TABLE 12 MERGER/ACQUISITION 38
TABLE 13 EXPANSION/ INVESTMENT 39
TABLE 14 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 43
TABLE 15 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS 43
TABLE 16 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 46
TABLE 17 CEPHEID: PRODUCT/SERVICE OFFERED 48
TABLE 18 BIOMERIEUX SA: PRODUCTS OFFERED 51
TABLE 19 SIEMENS MEDICAL SOLUTIONS USA, INC.: PRODUCTS OFFERED 54
TABLE 20 ABBOTT: PRODUCTS OFFERED 57
TABLE 21 ABBOTT: KEY DEVELOPMENTS 58
TABLE 22 T2 BIOSYSTEMS, INC: PRODUCTS OFFERED 60
TABLE 23 T2 BIOSYSTEMS, INC: KEY DEVELOPMENTS 61
TABLE 24 LUMINEX CORPORATION: PRODUCTS OFFERED 62
TABLE 25 BIONEER CORPORATION: PRODUCTS OFFERED 64
TABLE 26 QIAGEN: PRODUCTS OFFERED 66
?
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS 11
FIGURE 2 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET 13
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 19
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE US & CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS 22
FIGURE 5 DRIVERS IMPACT ANALYSIS 24
FIGURE 6 RESTRAINT IMPACT ANALYSIS 25
FIGURE 7 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, PRODUCT SEGMENT
ATTRACTIVENESS, 2019-2030 (USD MILLION) 27
FIGURE 8 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, BY PRODUCT,
2022 & 2030 (USD MILLION) 28
FIGURE 9 US AND CHINA: PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, BY COUNTRY,
2022 & 2030 (USD MILLION) 30
FIGURE 10 US AND CHINA: PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET SHARE (%), BY REGION, 2022 31
FIGURE 11 US MARKET ANALYSIS: PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, 2019-2030 (USD MILLION) 32
FIGURE 12 CHINA MARKET ANALYSIS: PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET, 2019-2030 (USD MILLION) 34
FIGURE 13 BENCHMARKING OF MAJOR COMPETITORS 36
FIGURE 14 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR
DIAGNOSIS OF SEPSIS MARKET 37
FIGURE 15 US AND CHINA PRE-TREATMENT KIT FOR MOLECULAR DIAGNOSIS OF SEPSIS MARKET: COMPETITIVE LANDSCAPE 38
FIGURE 16 MAJOR PLAYERS SALES, 2022 39
FIGURE 17 MAJOR PLAYER R&D EXPENDITURE, 2022 40
FIGURE 18 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT 42
FIGURE 19 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 44
FIGURE 20 F. HOFFMAN LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 45
FIGURE 21 F. HOFFMAN LA ROCHE LTD: SWOT ANALYSIS 46
FIGURE 22 BIOMERIEUX SA: FINANCIAL OVERVIEW SNAPSHOT 50
FIGURE 23 BIOMERIEUX SA: SWOT ANALYSIS 52
FIGURE 24 SIEMENS MEDICAL SOLUTIONS USA, INC.: FINANCIAL OVERVIEW SNAPSHOT 54
FIGURE 25 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 57
FIGURE 26 ABBOTT: SWOT ANALYSIS 58
FIGURE 27 T2 BIOSYSTEMS, INC: FINANCIAL OVERVIEW SNAPSHOT 60
FIGURE 28 BIONEER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 63
FIGURE 29 QIAGEN: FINANCIAL OVERVIEW SNAPSHOT 66
FIGURE 30 QIAGEN: SWOT ANALYSIS 67
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security